Screener
Biogen BIIB EBITDA
Discontinued — last reported Q2 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Biogen’s reported figures.
The source filing: Biogen’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
FAQ
- What is Biogen's EBITDA?
- Biogen (BIIB) reported EBITDA of $450.8M in Q2 2026.
- How has Biogen's EBITDA changed year-over-year?
- Biogen's EBITDA decreased by 55.4% year-over-year, from $1.01B to $450.8M.
- What is the long-term trend for Biogen's EBITDA?
- Over 4 years (2021 to 2025), Biogen's EBITDA has grown at a -6.1% compound annual growth rate (CAGR), from $3.33B to $2.59B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Biogen's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude